Dashboard
Manage Tickers

DRTSAlpha Tau Medical Ltd.

Nasdaq alphatau.com


$ 2.16 $ -0.03 (-1.59 %)    

Tuesday, 25-Jun-2024 15:58:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 2.16
$ 2.21
$ 2.14 x 100
$ 0.00 x 0
$ 2.15 - $ 2.21
$ 2.13 - $ 4.37
28,452
na
150.49M
$ 1.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alpha-tau-medical-publishes-pooled-analysis-of-alpha-dart-therapy-in-journal-cancers-data-from-4-international-trials-show-nearly-100-overall-response-rate-and-89-complete-response-rate-in-treated-lesions
Alpha Tau Medical Publishes Pooled Analysi...
06/25/2024 12:37:06

No Severe Long-Term Toxicities With 2-Year Local Recurrence-Free Survival At 77%

hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Alph...
05/22/2024 11:59:58

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

alpha-tau-medical-q1-eps-011-beats-012-estimate
Alpha Tau Medical Q1 EPS $(0.11) Beats $(0...
05/20/2024 20:04:43

Alpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0...

hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Alph...
05/16/2024 17:38:14

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

alpha-tau-treats-first-patient-with-liver-cancer-metastases-treated-in-study-of-alpha-dart
Alpha Tau Treats First Patient With Liver ...
05/13/2024 12:34:42

alpha-tau-presents-preclinical-data-demonstrating-abscopal-immune-effect-in-pancreatic-murine-tumor-models-at-estro-2024-congress-in-glasgow-initial-data-demonstrates-reduction-in-distant-pancreatic-cancer-tumor-growth-rate-starting-from-3-weeks-after-first-tumor-is-treated-with-alpha-dart-alone
Alpha Tau Presents Preclinical Data Demons...
05/06/2024 12:37:32

- Initial data demonstrates significant reduction in distant pancreatic cancer tumor growth rate starting from three weeks afte...

hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Alph...
03/12/2024 16:19:05

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

piper-sandler-reiterates-overweight-on-alpha-tau-medical-lowers-price-target-to-7
Piper Sandler Reiterates Overweight on Alp...
03/08/2024 14:51:47

Piper Sandler analyst Jason Bednar reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Overweight and lowers the price target ...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
01/10/2024 21:31:09

expert-ratings-for-alpha-tau-medical
Expert Ratings for Alpha Tau Medical
12/15/2023 15:01:00

citigroup-initiates-coverage-on-alpha-tau-medical-with-buy-rating-announces-price-target-of-8
Citigroup Initiates Coverage On Alpha Tau ...
12/15/2023 14:43:25

Citigroup analyst Ashiq Mubarack initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Buy rating and announces Price...

alpha-tau-announces-interim-results-from-safety-and-feasibility-trial-of-alpha-dart-treatment-of-advanced-pancreatic-cancer
Alpha Tau Announces Interim Results From S...
11/28/2023 13:33:10

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no pr...

alpha-tau-submits-to-japanese-pmda-for-pre-market-approval-of-alpha-dart-in-patients-with-recurrent-head-and-neck-cancer
Alpha Tau Submits To Japanese PMDA For Pre...
11/20/2023 13:31:23

Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ:DRTS, DRTSW)))), the developer of the innovative alpha-radiation cancer th...

hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Alph...
11/20/2023 11:13:04

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

analyst-ratings-for-alpha-tau-medical
Analyst Ratings for Alpha Tau Medical
11/17/2023 18:00:22

piper-sandler-maintains-overweight-on-alpha-tau-medical-lowers-price-target-to-8
Piper Sandler Maintains Overweight on Alph...
11/17/2023 17:15:23

Piper Sandler analyst Jason Bednar maintains Alpha Tau Medical (NASDAQ:DRTS) with a Overweight and lowers the price target f...

alpha-tau-medical-9m-eps-031
Alpha Tau Medical 9M EPS $(0.31)
11/16/2023 21:36:59

alpha-tau-enters-into-long-term-lease-of-site-in-new-hampshire-for-second-us-manufacturing-facility
Alpha Tau Enters Into Long-Term Lease Of S...
10/30/2023 12:36:14

Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)))), the developer of the innovative...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
10/25/2023 21:31:23

hc-wainwright--co-reiterates-buy-on-alpha-tau-medical-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Alph...
09/20/2023 10:38:18

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $9 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)